News
AI and clinical transformation: High-value or hype? Later in the Summit, Novo Nordisk shared its own strategy for transforming clinical research through the use of data and AI. The clinical ...
Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...
Stock markets in North America was a roller coaster on Wednesday and Thursday after U.S. President Donald Trump paused his so ...
Novo Nordisk has reported the second phase 3 trial of its new obesity hopeful CagriSema but, as with the first, the topline weight-loss result has sent its shares into a sharp decline. The stock ...
HYDERABAD, April 7 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with ...
I et interview med Ekstra Bladet undskylder produktionsdirektør i Novo Nordisk Michael Hallgren for sagen om de mange migrantarbejdere, der er blevet underbetalt og udnyttet på medicinalkæmpens ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results